Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment

Bibliographic Details
Main Authors:	Alexeev, Vasiliy Grigorievich, Kuznecova, Ludmila Vasilievna
Format:	Online
Language:	English
Published:	Dove Medical Press 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218788/

Similar Items

Pharmacovigilance of serotonin reuptake inhibitors
by: Darpan Kaur, et al.
Published: (2013-01-01)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
by: Cerit, Levent
Published: (2016)

Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response
by: Panlilio, Jennifer M., et al.
Published: (2016)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
by: Pleym, Hilde, et al.
Published: (2011)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring
by: Olivier, J. D. A., et al.
Published: (2013)

Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors‘ Behavioral and Neurochemical Effects
by: Munari, Leonardo, et al.
Published: (2015)

Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity
by: Tiradentes, R.V., et al.
Published: (2014)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
by: POP, ANCA, et al.
Published: (2015)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
by: Wozniak, Greta, et al.
Published: (2011)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
by: Kobayashi, Katsunori, et al.
Published: (2011)

Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study
by: Carvajal, Alfonso, et al.
Published: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Diav-Citrin, Orna, et al.
Published: (2012)

Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
by: Chau, Kim, et al.
Published: (2012)

Prediction of Selective Serotonin Reuptake Inhibitor Response Using Diffusion-Weighted MRI
by: DeLorenzo, Christine, et al.
Published: (2013)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
by: Ashbury, Janet E., et al.
Published: (2012)

The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
by: An, Ki-Yong, et al.
Published: (2013)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
by: Vasudev, Rahul, et al.
Published: (2016)

Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
by: Nezafati, Mohammad Hassan, et al.
Published: (2016)

Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study
by: Molero, Yasmina, et al.
Published: (2015)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
by: Jury, Nicholas J., et al.
Published: (2015)

Selective Serotonin Reuptake Inhibitors and Night Sweats in a Primary Care Population
by: Mold, James W., et al.
Published: (2015)

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†
by: Montgomery, Stuart A, et al.
Published: (2014)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
by: Clayton, Anita H, et al.
Published: (2014)

Transient Serotonin Syndrome by Concurrent Use of Electroconvulsive Therapy and Selective Serotonin Reuptake Inhibitor: A Case Report and Review of the Literature
by: Okamoto, Nagahisa, et al.
Published: (2012)

Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
by: Kumar, Vivek, et al.
Published: (2015)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
by: Shakoor, Muhammad Tariq, et al.
Published: (2014)

Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release
by: Dankoski, Elyse C., et al.
Published: (2016)

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
by: Keating, Charlotte, et al.
Published: (2013)

A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment
by: Ravinder, S, et al.
Published: (2013)

Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients
by: Kostev, Karel, et al.
Published: (2014)

The Effect of Antenatal Depression and Selective Serotonin Reuptake Inhibitor Treatment on Nerve Growth Factor Signaling in Human Placenta
by: Kaihola, Helena, et al.
Published: (2015)

Serum S100B Protein Levels in Patients with Panic Disorder: Effect of Treatment with Selective Serotonine Reuptake Inhibitors
by: Cagatay Kaya, Berna, et al.
Published: (2015)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
by: Gjestad, Caroline, et al.
Published: (2015)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
by: Praharaj, Samir Kumar
Published: (2011)

Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy
by: Jocelyn Y. Cheng
Published: (2018-01-01)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
by: Patel, Harish, et al.
Published: (2015)

Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome
Published: (2016)

Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome
by: Benavides, David R., et al.
Published: (2016)

Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice
by: Redaelli, Marco, et al.
Published: (2015)

Cellular Correlates of Enhanced Anxiety Caused by Acute Treatment with the Selective Serotonin Reuptake Inhibitor Fluoxetine in Rats
by: Ravinder, Shilpa, et al.
Published: (2011)